Replies to post #52021 on RespireRx Pharmaceuticals Inc (fka RSPI)

[LTListener]

While the jeopardy tune continues to play, I guess one interesting question would be is this statement from a previous PR still accurate?

"the plan is to begin testing in patients by the 4th quarter 2024"

Could be interesting if the stock is still on the EM while trials are beginning and they start to garner attention.